Robert M. Lorence

4.5k citations
51 papers · 3.7k · 2 hit papers · h-index 29

Impact in

  • Oncology top 2%
    • CAR-T cell therapy research
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
  • Genetics top 1%
    • Virus-based gene therapy research

Papers in

    • Virus-based gene therapy research 16
    • Photosynthetic Processes and Mechanisms 10
    • ATP Synthase and ATPases Research 3

Robert M. Lorence

49 papers receiving 3.6k citations

Robert M. Lorence's Hit Papers

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial 2012 · 334 citations
3340+4+9Years since publication250500750

Peers

Robert M. Lorence
Comparison fields: 5 of 109
  • Oncology 1.3k
  • Genetics 1.2k
  • Pulmonary and Respiratory Medicine 1.2k
  • Animal Science and Zoology 348
  • Molecular Biology 1.4k
Replace Dana M. Fowlkes with:
Dana M. Fowlkes United States
James Barsoum United States
Grazyna Kochan Spain
Thomas Y. Shih United States
Irène Joab France
Clifford D. Mol United States
Krishna Rajarathnam United States
Emma Eriksson Sweden
Shelby L. Berger United States
Yanhui Xu China
Robert M. Lorence relative to Dana M. Fowlkes United States Dana M. Fowlkes's profile →
Citations per field
00.5×12×
Dana M. Fowlkes · 1×
Citations per year

Countries citing papers authored by Robert M. Lorence

Since Specialization
Citations

This map shows the geographic impact of Robert M. Lorence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Lorence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Lorence more than expected).

Fields of papers citing papers by Robert M. Lorence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Lorence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Lorence. The network helps show where Robert M. Lorence may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert M. Lorence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert M. Lorence Line = papers co-authored together Robert M. Lorence links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
Hit paper breakdown →
2012778
2
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Hit paper breakdown →
2012334
3 2002316
4 1992200
5 2012136
6 2001135
7
Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
1994129
8 1988125
9 2006104
10 1994102
11 1991101
12 200799
13 198695
14 200793
15 199280
16 198079
17 199173
18 201868
19 198463
20 201361

About Robert M. Lorence

Robert M. Lorence is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Oncology, having authored 51 papers that have together received 3.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), Lung Cancer Treatments and Mutations (15 papers), Photosynthetic Processes and Mechanisms (10 papers), Virology and Viral Diseases (8 papers), HER2/EGFR in Cancer Research (4 papers), Photoreceptor and optogenetics research (4 papers), ATP Synthase and ATPases Research (3 papers) and Enzyme Structure and Function (3 papers). The work is most often cited by research in Oncology (1.3k citations), Genetics (1.2k citations), Pulmonary and Respiratory Medicine (1.2k citations), Animal Science and Zoology (348 citations) and Molecular Biology (1.4k citations). Robert M. Lorence has collaborated with scholars based in United States, Taiwan and Canada. Frequent co-authors include Robert B. Gennis, Robert Walter, James Chih‐Hsin Yang, Mark E. Peeples, Kirk W. Reichard, Keith W. Kelley, Wu‐Chou Su, Michael K. Bamat, Xiuyu Julie Cong and Mehdi Shahidi. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, European Journal of Cancer, Journal of Thoracic Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact